11/27
06:16 pm
ardx
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/25
07:19 am
ardx
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Ardelyx (NASDAQ:ARDX) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/25
07:19 am
ardx
Ardelyx (NASDAQ:ARDX) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.
Low
Report
Ardelyx (NASDAQ:ARDX) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.
11/19
04:41 am
ardx
Can Ardelyx's (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? [Yahoo! Finance]
Medium
Report
Can Ardelyx's (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? [Yahoo! Finance]
11/18
05:22 am
ardx
BTIG Maintains a Buy on Ardelyx, Inc (ARDX) [Yahoo! Finance]
Low
Report
BTIG Maintains a Buy on Ardelyx, Inc (ARDX) [Yahoo! Finance]
11/7
04:05 pm
ardx
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
Low
Report
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
11/5
08:00 am
ardx
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
Medium
Report
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
11/4
11:54 am
ardx
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Piper Sandler from $9.00 to $10.00. They now have a "neutral" rating on the stock.
Medium
Report
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Piper Sandler from $9.00 to $10.00. They now have a "neutral" rating on the stock.
11/4
08:00 am
ardx
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
Low
Report
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
11/3
03:44 pm
ardx
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Citigroup Inc. from $10.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at Citigroup Inc. from $10.00 to $11.00. They now have a "buy" rating on the stock.
11/1
04:32 am
ardx
Ardelyx GAAP EPS of $0.00 beats by $0.06, revenue of $110.3M beats by $9.76M [Seeking Alpha]
Low
Report
Ardelyx GAAP EPS of $0.00 beats by $0.06, revenue of $110.3M beats by $9.76M [Seeking Alpha]
10/31
02:44 pm
ardx
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at TD Cowen from $9.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Ardelyx (NASDAQ:ARDX) had its price target raised by analysts at TD Cowen from $9.00 to $10.00. They now have a "buy" rating on the stock.
10/31
11:03 am
ardx
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Ardelyx (NASDAQ:ARDX) had its "buy" rating reaffirmed by analysts at Cowen Inc.
10/30
11:10 pm
ardx
Ardelyx raises 2025 IBSRELA revenue guidance to $270M-$275M as growth accelerates [Seeking Alpha]
Low
Report
Ardelyx raises 2025 IBSRELA revenue guidance to $270M-$275M as growth accelerates [Seeking Alpha]
10/30
04:01 pm
ardx
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
High
Report
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/28
08:01 am
ardx
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
Low
Report
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
10/21
08:00 am
ardx
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
Medium
Report
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
10/14
01:25 am
ardx
Where Does Ardelyx Stand After Its Recent 24% Share Price Drop? [Yahoo! Finance]
Low
Report
Where Does Ardelyx Stand After Its Recent 24% Share Price Drop? [Yahoo! Finance]
10/13
08:39 am
ardx
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer [Yahoo! Finance]
Low
Report
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer [Yahoo! Finance]
10/13
08:35 am
ardx
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
Low
Report
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
10/13
08:30 am
ardx
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
Low
Report
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
10/3
03:30 pm
ardx
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Ardelyx (NASDAQ:ARDX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/24
10:51 am
ardx
Is This Under-$10 Stock the Next Big Biotech Winner? [Yahoo! Finance]
Low
Report
Is This Under-$10 Stock the Next Big Biotech Winner? [Yahoo! Finance]